New HIV drug passes heart safety check in healthy volunteers
NCT ID NCT07305831
First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 17 times
Summary
This study tested whether an experimental HIV medicine called ulonivirine (MK-8507) affects heart rhythm. 62 healthy adults received the drug or a placebo, and researchers measured changes in their heart's electrical activity. The goal was to ensure the drug is safe for the heart before moving to larger trials. No treatment benefit was expected since participants were healthy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Early Phase Services (0001)
San Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.